GRIbenzinga

Why Is Nano Cap GRI Bio Stock Skyrocketing On Tuesday?

Summary

GRI Bio reported interim Phase 2a results for GRI-0621 in IPF, showing safety and no significant cholesterol changes.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on April 1, 2025 by benzinga